Follow The Filings

EHC Encompass Health

Encompass Health earnings company data as of 8:01 AM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 1.37 1.52 Beat +10.9%
Rev $1.60B $1.61B In line +0.5%

Insider trades

Open-market buys and sales by EHC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EHC insider trades
  • None no insider bought on the open market
  • $47.8M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Andrew L. Price Chief Accounting Officer
    Sale
    $630K 5,211 shares at $120.93 7% of stake
    Traded Aug 31 Filed Sep 1
  2. John Patrick Darby EVP, Gen Counsel & Secretary
    Sale
    $588K 4,858 shares at $121.09 6.1% of stake
    Traded Aug 31 Filed Sep 1
  3. Douglas E. Coltharp CFO
    Sale
    $2.4M 18,869 shares at $125.38 27% of stake
    Traded Aug 10 Filed Aug 11
  4. Mark J. Tarr CEO
    Sale
    $21.7M 173,148 shares at $125.47 39% of stake
    Traded Aug 10 Filed Aug 11
  5. John Patrick Darby EVP, Gen Counsel & Secretary
    Sale
    $1.1M 8,906 shares at $125.95 11% of stake
    Traded Aug 10 Filed Aug 11
  6. Douglas E. Coltharp CFO
    Sale
    $3M 27,694 shares at $106.83 29% of stake
    Traded May 15 Filed May 18
  7. Patrick William Tuer COO
    Sale
    $71K 682 shares at $104.56 2.7% of stake
    Traded May 11 Filed May 12
  8. Edmund Fay Sr. Vice Pres. and Treasurer
    Sale
    $1.3M 11,937 shares at $107.00 12% of stake
    Traded Mar 9 Filed Mar 10
  9. Mark J. Tarr CEO
    Sale
    $16.7M 150,000 shares at $111.64 29% of stake
    Traded Feb 11 Filed Feb 12
  10. Patrick William Tuer COO
    Sale
    $302K 2,804 shares at $107.62 15% of stake
    Traded Feb 10 Filed Feb 10

Also filed in the last 12 months, not counted as buying or selling: 67 stock grants, 28 share withholdings for taxes, 2 option exercises, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 7.01,9.01
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —
8-K 8.01
10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G/A —
8-K 1.01,2.03,9.01
8-K 1.01,8.01,9.01
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf